Praxis Precision Medicines (PRAX) Stock: Buy, Sell, or Hold?
PRAX - Praxis Precision Medicines, Inc. Common Stock
$295.51
8.60 (3.00%)
▲
5d:
+5.25%
30d:
-17.34%
90d:
-5.74%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When PRAX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PRAX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PRAX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PRAX is currently trading at $295.51, which is considered slightly low relative to its 30-day fair value range of $292.67 to $356.40.
Technical Outlook: Technically, PRAX is showing sideways momentum. Immediate support is located at $275.89, while resistance sits at $312.46.
Market Sentiment: PRAX scores 96/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $638.68 (+122.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PRAX is showing sideways momentum. Immediate support is located at $275.89, while resistance sits at $312.46.
Market Sentiment: PRAX scores 96/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $638.68 (+122.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$292.67 -
$356.40
Company Quality Score
67/100
(BUY)
Options IV Signal
57th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
89.6%
Protect Your Profits
Holding PRAX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 57th percentile)
- BULLISH: Strong technical setup (96/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 122.6% below Wall St target ($638.68)
- CAUTION: Bottoming setup, but lagging the sector by 31% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$292.67 -
$356.40
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$29.92
(10.1%)
Support & Resistance Levels
Support Level
$275.89
Resistance Level
$312.46
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-30.87
Wall Street Target
$638.68
(+122.6%)
Revenue Growth (YoY)
1349.1%
Share & Embed Analysis
Last updated: October 02, 2026 3:59 PM ET
Data refreshes hourly during market hours. Next update: 4:59 PM
Data refreshes hourly during market hours. Next update: 4:59 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRAX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 65 BUY |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 52 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 51 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
10 analysts |
$70 | 68 BUY |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
13 analysts |
$107 | 67 BUY |
Advanced PRAX Option Strategies
Professional options setups generated by AI based on today's PRAX price and gamma walls.
